×
About 4,895 results

ALLMedicine™ Hyponatremia Center

Research & Reviews  1,576 results

Vasopressin-Induced Hyponatremia in Patients With Aneurysmal Subarachnoid Hemorrhage: A...
https://doi.org/10.1177/08971900211053497
Journal of Pharmacy Practice; Subba H, Riker RR et. al.

Oct 23rd, 2021 - Vasopressin may be administered to treat vasospasm following aneurysmal subarachnoid hemorrhage (aSAH). The objectives of this study were to describe five cases of suspected vasopressin-induced hyponatremia after aSAH and to review the literature....

Valproate Toxicity Workup
https://emedicine.medscape.com/article/819315-workup

Oct 21st, 2021 - Approach Considerations Determination of the valproate (valproic acid [VPA]) level is obviously warranted. Reviews have shown that nearly 20% of VPA overdose patients may present with initial VPA concentrations that are in the therapeutic range, o...

External Validation of a Prediction Model for Acute Kidney Injury Following Noncardiac ...
https://doi.org/10.1001/jamanetworkopen.2021.27362
JAMA Network Open; Nishimoto M, Murashima M et. al.

Oct 19th, 2021 - The Simple Postoperative AKI Risk (SPARK) index is a prediction model for postoperative acute kidney injury (PO-AKI) in patients undergoing noncardiac surgery. External validation has not been performed. To externally validate the SPARK index. Thi...

Safety and efficacy of human serum albumin treatment in patients with cirrhotic ascites...
https://doi.org/10.1016/j.aohep.2021.100547
Annals of Hepatology; Shrestha DB, Budhathoki P et. al.

Oct 10th, 2021 - Ascites is the most common presentation of decompensated liver cirrhosis. It is treated with therapeutic paracentesis which is associated with several complications. The role of human albumin in patients with cirrhotic ascites remains elusive and ...

Pancreatic neuroendocrine tumor producing vasopressin: A case report.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500607
Medicine Li J, Zhang X et. al.

Oct 9th, 2021 - Functional pancreatic neuroendocrine tumors (pNETs) rarely produce vasopressin. Here, we reported a case of pNET producing vasopressin in a 78-year-old man with hyponatremia. The patient presented with anorexia approximately 4 years ago, and the l...

see more →

Guidelines  6 results

International Continence Society consensus on the diagnosis and treatment of nocturia.
https://doi.org/10.1002/nau.23939
Neurourology and Urodynamics; Everaert K, Hervé F et. al.

Feb 20th, 2019 - Patients with nocturia have to face many hurdles before being diagnosed and treated properly. The aim of this paper is to: summarize the nocturia patient pathway, explore how nocturia is diagnosed and treated in the real world and use the Delphi m...

Choosing Wisely in pediatric anesthesia: An interpretation from the German Scientific W...
https://doi.org/10.1111/pan.13383
Paediatric Anaesthesia; Becke K, Eich C et. al.

Jun 1st, 2018 - Inspired by the Choosing Wisely initiative, a group of pediatric anesthesiologists representing the German Working Group on Paediatric Anaesthesia (WAKKA) coined and agreed upon 10 concise positive ("dos") or negative ("don'ts") evidence-based rec...

Approach to hyponatremia according to the clinical setting: Consensus statement from th...
https://doi.org/10.1007/s40618-017-0776-x
Journal of Endocrinological Investigation; Sbardella E, Isidori AM et. al.

Nov 21st, 2017 - Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM).|2017|Sbardella E,Isidori AM,A...

Perioperative intravenous fluid therapy in children: guidelines from the Association of...
https://doi.org/10.1111/pan.13007
Paediatric Anaesthesia; Sümpelmann R, Becke K et. al.

Oct 18th, 2016 - This consensus- based S1 Guideline for perioperative infusion therapy in children is focused on safety and efficacy. The objective is to maintain or re-establish the child's normal physiological state (normovolemia, normal tissue perfusion, normal...

SEOM guidelines on hydroelectrolytic disorders.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239780
Clinical & Translational Oncology : Official Publication ... De las Peñas R, Escobar Y et. al.

Oct 12th, 2014 - Hydroelectrolytic disorders are one of the most common metabolic complications in cancer patients. Although often metabolic alterations affecting various ions are part of the manifestations of the oncological disease, even in the form of paraneopl...

see more →

Drugs  136 results see all →

Clinicaltrials.gov  28 results

Effects of the SGLT2-inhibitor Empagliflozin on Patients With Chronic SIADH - the SANDx Study
https://clinicaltrials.gov/ct2/show/NCT03202667

Oct 4th, 2021 - Syndrome of inappropriate antidiuresis (SIADH) is characterized by an imbalance of antidiuretic vasopressin (AVP) secretion. The impaired AVP regulation leads to water retention and secondary natriuresis and is a common cause for hyponatremia. Esp...

To Study Effect of the Combination of Midodrine and Tolvaptan Versus Tolvaptan Alone in Patients With Severe Hyponatremia in Cirrhosis(TOLMINA Trial)
https://clinicaltrials.gov/ct2/show/NCT05060523

Sep 29th, 2021 - Aim and Objective - AIM: • To study effect of the combination of Midodrine and Tolvaptan versus Tolvaptan alone in patients with severe hyponatremia in cirrhosis. PRIMARY Objective : • To study the Improvement in sodium concentration from base lin...

Efficacy and Safety of Carvedilol in Cirrhosis Patients With Uncomplicated Ascites Without High Risk Esophageal Varices
https://clinicaltrials.gov/ct2/show/NCT05057572

Sep 27th, 2021 - AIM-To compare the safety and efficacy of addition of carvedilol to SMT (diuretics +/- albumin) compared to SMT alone in the prevention of complicated ascites (refractory ascites, AKI-HRS, SBP or severe hyponatremia) at 1year. Methodology: Study p...

Efficacy and Safety of Rapid Intermittent Correction Compared With Slow Continuous Correction in Patients With Severe Hypernatremia
https://clinicaltrials.gov/ct2/show/NCT04949139

Jul 2nd, 2021 - Hypernatremia is defined as serum sodium (sNa) levels above 145 mmol/L and is caused by abnormalities in water balance, mainly in children, elderly, and critically ill patients. It occurs in 3% of hospitalized patients and in 9% of critically ill ...

Sepsis Associated Encephalopathy (SAE) Biomarkers
https://clinicaltrials.gov/ct2/show/NCT03133208

Jun 28th, 2021 - Sepsis associated encephalopathy (SAE) is a common neurological complication of sepsis that is often associated with worse prognosis, yet remains poorly understood. It occurs in the absence of direct brain infection or other types of disease-assoc...

see more →

News  210 results

AVANTI: Could a 'Vaptan' Replace Loop Diuretics in Acute HF?
https://www.medscape.com/viewarticle/957389

Sep 17th, 2021 - This transcript has been edited for clarity. Ileana L. Piña, MD, MPH: Hello. This is Ileana Piña, professor of medicine at Central Michigan University and adjunct professor at Case Western Reserve. This is my blog. Today I am talking to you during...

An unquenchable thirst
https://www.mdedge.com/psychiatry/article/244809/schizophrenia-other-psychotic-disorders/unquenchable-thirst
Amy Gallop, MD, Ellen Kim, MD et. al.

Sep 1st, 2021 - CASE Unresponsive after a presumed seizure Mr. F, age 44, has schizophrenia.

In Early Lung Cancer, Immunotherapy Plus Targeted Radiation May Up Response Rate
https://www.medscape.com/viewarticle/953371

Jun 21st, 2021 - NEW YORK (Reuters Health) - Patients with non-small-cell lung cancer (NSCLC) may respond more quickly to neoadjuvant durvalumab combined with stereotactic body radiotherapy than to immunotherapy alone, an early industry-funded trial suggests. "In ...

Finding the Golden Ticket in Cholangiocarcinoma: Entering the Era of Precision Medicine
https://www.onclive.com/view/finding-the-golden-ticket-in-cholangiocarcinoma-entering-the-era-of-precision-medicine

May 10th, 2021 - The highly heterogeneous nature of cholangiocarcinoma at the genomic, epigenetic, and molecular levels has led to the development of effective new treatments for patients with these rare malignant tumors. Cholangiocarcinoma, the second most common...

Infigratinib for CCA
https://www.onclive.com/view/infigratinib-for-cca

Apr 2nd, 2021 - Transcript: Ghassan Abou-Alfa, MD, MBA: Let’s dissect the genetic makeup of those tumors more, and let’s talk a little bit more about those therapies. I’ll start with the FGFR2 [fibroblast growth factor receptor 2] fusion protein. Andrew, for a...

see more →

Patient Education  2 results see all →